Ashley M. Schnakenberg Martin
Ashley M. Schnakenberg Martin
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
DL Boggs, T Surti, A Gupta, S Gupta, M Niciu, B Pittman, ...
Psychopharmacology 235, 1923-1932, 2018
Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans
M Ranganathan, A Schnakenberg, PD Skosnik, BM Cohen, B Pittman, ...
Biological psychiatry 72 (10), 871-879, 2012
Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ9-THC in humans
DC D'souza, DJ Fridberg, PD Skosnik, A Williams, B Roach, N Singh, ...
Neuropsychopharmacology 37 (7), 1632-1646, 2012
Acute effects of THC on time perception in frequent and infrequent cannabis users
RA Sewell, A Schnakenberg, J Elander, R Radhakrishnan, A Williams, ...
Psychopharmacology 226, 401-413, 2013
Metacognition and recovery in schizophrenia: From research to the development of metacognitive reflection and insight therapy
PH Lysaker, M Kukla, JL Vohs, AM Schnakenberg Martin, KD Buck, ...
Journal of Experimental Psychopathology 10 (1), 2043808718814992, 2019
Meaning, integration, and the self in serious mental illness: Implications of research in metacognition for psychiatric rehabilitation.
PH Lysaker, M Kukla, BL Leonhardt, JA Hamm, A Schnakenberg Martin, ...
Psychiatric Rehabilitation Journal 43 (4), 275, 2020
Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information
M Ranganathan, R Radhakrishnan, PH Addy, AM Schnakenberg-Martin, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 79, 176-183, 2017
The safety of studies with intravenous Δ9-tetrahydrocannabinol in humans, with case histories
M Carbuto, RA Sewell, A Williams, K Forselius-Bielen, G Braley, J Elander, ...
Psychopharmacology 219, 885-896, 2012
GABA deficits enhance the psychotomimetic effects of Δ9-THC
R Radhakrishnan, PD Skosnik, J Cortes-Briones, RA Sewell, M Carbuto, ...
Neuropsychopharmacology 40 (8), 2047-2056, 2015
Aberrant structural–functional coupling in adult cannabis users
DJ Kim, AM Schnakenberg Martin, YW Shin, HJ Jo, H Cheng, ...
Human brain mapping 40 (1), 252-261, 2019
Compared to high and low cannabis use, moderate use is associated with fewer cognitive deficits in psychosis
AMS Martin, KA Bonfils, BJ Davis, EA Smith, K Schuder, PH Lysaker
Schizophrenia Research: Cognition 6, 15-21, 2016
The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition
S Helle, EM Løberg, R Gjestad, AMS Martin, PH Lysaker
Psychiatry Research 250, 92-98, 2017
An investigation of neurochemical changes in chronic cannabis users
SD Newman, H Cheng, A Schnakenberg Martin, U Dydak, ...
Frontiers in human neuroscience 13, 318, 2019
Treatment outcomes in individuals diagnosed with comorbid opioid use disorder and Posttraumatic stress disorder: A review
S Meshberg-Cohen, RR MacLean, AMS Martin, M Sofuoglu, IL Petrakis
Addictive behaviors 122, 107026, 2021
Auditory feature perception and auditory hallucinatory experiences in schizophrenia spectrum disorder
AM Schnakenberg Martin, L Bartolomeo, J Howell, WP Hetrick, ...
European archives of psychiatry and clinical neuroscience 268, 653-661, 2018
Altered cerebellar-cortical resting-state functional connectivity in cannabis users
AM Schnakenberg Martin, DJ Kim, SD Newman, H Cheng, WP Hetrick, ...
Journal of Psychopharmacology 35 (7), 823-832, 2021
An investigation of the relationship between glutamate and resting state connectivity in chronic cannabis users
SD Newman, H Cheng, DJ Kim, A Schnakenberg-Martin, U Dydak, ...
Brain imaging and behavior 14, 2062-2071, 2020
Differential cognitive performance in females and males with regular cannabis use
AMS Martin, DC D’Souza, SD Newman, WP Hetrick, BF O’Donnell
Journal of the International Neuropsychological Society 27 (6), 570-580, 2021
In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive …
EAD Schindler, AM Schnakenberg Martin, RA Sewell, M Ranganathan, ...
Psychopharmacology 237, 3097-3107, 2020
Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism
M Ranganathan, RA Sewell, M Carbuto, J Elander, A Schnakenberg, ...
Psychopharmacology 231, 2385-2393, 2014
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20